Jeremy Golden

Jeremy Golden

About
Jeremy Golden is a U.S.-based writer who has contributed stories to newspapers, magazines and online publications across the Southeast. He has experience writing about finance, food, small businesses, athletics and other topics.
New Study Shows Cardio Diagnostics' (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
Sponsored
3 Trends In Healthcare Guided By AI And The Companies Behind The Innovation
Sponsored
The Growing Market Demand For Waste Energy Solutions And How Sky Quarry Has Prepared Itself To Meet It
Sponsored
Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests
Sponsored
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
Sponsored
Unlocking The Power Of Immunotherapy: Elicio Therapeutics' (NASDAQ: ELTX) Novel AMP Platform
Sponsored
Helping Build A Sustainable Future For Construction Materials – Sky Quarry's Innovative Approach To Recycling Shingles, Recovering Oil
Sponsored
Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors
Sponsored
Syra Health (NASDAQ: SYRA) Wins $650,000 Healthcare Quality Improvement Contract
Sponsored
Sky Quarry Is Paving The Way Toward A Potential Solution For The Multi-Billion Dollar Waste Asphalt Shingle Problem
Sponsored
Innoveren Scientific's (OTCMKTS: IVRN) 510(k) Submission Sparks A New Hope For Patients Living With Chronic Non-Healing Wounds
Sponsored
Oncolytics Biotech (NASDAQ: ONCY) (TSX: ONC) Fights Cancer With Pelareorep, Which Has Received FDA Fast Track Designation For Breast And Pancreatic Cancer
Sponsored
Moving Fast: Candel's (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
Sponsored
Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
Sponsored
Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals
Sponsored
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. 
Sponsored
Syra Health (NASDAQ: SYRA) Becomes A Subcontractor For The $75 Billion Federal Contract Awarded To Caduceus Healthcare
Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company has been selected as a subcontractor for a contract awarded to Caduceus Healthcare, Inc.
Sponsored
Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies
A clinical-stage biopharmaceutical company looks forward to the year ahead with several promising developments in motion. 
Sponsored
BlackRock Acquires Stake In Cardio Diagnostics
BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb.
Sponsored
Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
A clinical-stage biotechnology company has published promising preclinical data in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR).   
Sponsored